Brief: Aptevo Therapeutics - Fuad El-Hibri, Chairman Of Board, Notified Co Of His Retirement, Resignation As A Director Of Co, Effective April 1, 2022
Jan 21 (Reuters) - Aptevo Therapeutics Inc APVO.O :
* APTEVO THERAPEUTICS - FUAD EL-HIBRI, CHAIRMAN OF BOARD,
NOTIFIED
CO OF HIS RETIREMENT, RESIGNATION AS A DIRECTOR OF CO, EFFECTIVE
APRIL 1, 2022
* APTEVO THERAPEUTICS - BOARD APPOINTED JOHN NIEDERHUBER,
M.D. AS
CHAIRMAN OF THE BOARD EFFECTIVE APRIL 1, 2022
* APTEVO THERAPEUTICS - EFFECTIVE APRIL 1, 2022, THE SIZE OF
THE
COMPANY’S BOARD OF DIRECTORS WILL BE REDUCED FROM SEVEN TO SIX
DIRECTORS - SEC FILING
Source text: [ID: https://bit.ly/3Ky54qM]
Further company coverage: APVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary